Partner Headlines - ESRX

  1. Pioneer Fundamental Growth Fund: Why Is It Revving Up?

    IBD
  2. Horizon Pharma Soars On Q4 Beat, Guidance Raise

    IBD
  3. Catamaran EPS Tops, But Stock Falls On Weak Guidance

    IBD
  4. 10 Stocks You Should Be Watching Today

    Benzinga
  5. EXPRESS SCRIPTS

    IBD
  6. UPDATE: Express Scripts Tops Q4 Expectations, Shares Rise After ...

    Benzinga
  7. Nasdaq Stretches Win Streak To 9 Days

    IBD
  8. Earnings Scheduled For February 23, 2015

    Benzinga
  9. Must Watch Stocks for Today

    Benzinga
  10. Stocks Cap Short Week With Gains; Salix Up On Buyout Hopes

    IBD
  11. Rolfe Adds One Company to Portfolio in Fourth Quarter

    GuruFocus
  12. Analyzing Needham Growth Fund's Pick: Express Scripts (ESRX)

    GuruFocus
  13. Analyzing Needham Growth Fund's Pick: CarMax (KMX)

    GuruFocus
  14. Rite Aid Stock Soars, Steps Up Competition With CVS

    IBD
  15. Gilead Sciences Offering Fresh Wave Of Competition To AbbVie's ...

    GuruFocus
  16. Thornburg Value Fund Q4 2014 Commentary

    GuruFocus
  17. Gilead Q4 Earnings Beat, But Price War Taking Toll

    IBD
  18. Baird Remains Buyers Of Gilead Before Earnings Release

    Benzinga
  19. Cramer Gives His Opinion On Whole Foods Market, Whiting Petroleum ...

    Benzinga
  20. AmerisourceBergen Hits New High On Earnings, Outlook

    IBD
  21. Has Gilead Sciences Been Able To Maintain Its Lead Run In The ...

    GuruFocus
  22. Gilead, AbbVie Hepatitis C Price Cuts Will Hit Sales

    IBD
  23. Why Drug Pricing Could Bring Volatility To The Biotech Sector ...

    Benzinga
  24. Aetna Sides With Gilead In Hepatitis C Drug Battle

    IBD
  25. What The Market's Reading: An Iraq Ramp-Up & Biotech Moves

    Benzinga
  26. Steven Romick Buys 7 US and International Stocks in Q4

    GuruFocus
  27. Express Scripts Eyes New Price War: Anti-PCSK9 Drugs

    IBD
  28. Cholesterol Drug Costs Eyed

    IBD
  29. AbbVie Inc.'s Forthcoming Future Looks Optimistic

    GuruFocus
  30. Amgen's Decline May Be Linked To Comments Of Express Script's ...

    Benzinga
  31. Biotechs Presenting At The J.P. Morgan Healthcare Conference: ...

    Benzinga
  32. AbbVie Stock Down After Guidance, Downgrade

    IBD
  33. Gilead Strikes Deal with CVS, Hits Back AbbVie

    GuruFocus
  34. Hepatitis Drugs Vie For Share

    IBD
  35. CVS Covering Gilead HCV Drugs, Countering AbbVie

    IBD
  36. Stocks Lose More Ground; Gilead Sciences Rises

    IBD
  37. CVS Picks Gilead Hep C Drugs As Price War Looms

    IBD
  38. Drug Distributor Reaps The Rewards Of Strategy Shift

    IBD
  39. Express Scripts Stock Dominated Q4; Which Funds Might've Won?

    Benzinga
  40. 5 Biotech Stocks With Big News Due In January

    IBD
  41. Stocks Hold Near Highs; LifeLock Breaks Out

    IBD
  42. Facebook Among IBD 50's Top 5 Earnings Kings In 2014

    IBD
  43. IBD 50: Biotechs Hammered, Then Find Support

    IBD
  44. First Pacific Advisors' Third-Quarter Investment in Yahoo! Increases ...

    GuruFocus
  45. Biotech Stocks Take A Beating, But Find Support

    IBD
  46. Stocks Score Small Gains; Virgin America Takes Flight

    IBD
  47. How Gilead And Johnson & Johnson's Tumble Affected These Hedge ...

    Benzinga
  48. Evercore ISI Analyst: 160,000 Patients Affected by AbbVie Hepatitis ...

    Benzinga
  49. Toys, Department Stores Rock, But Biotechs Tumble

    IBD
  50. Deutsche Bank Analyst Sees Gilead Sciences Vs. AbbVie 'Price ...

    Benzinga
  51. AbbVie Drug Displaces Gilead

    IBD
  52. Actavis, Valeant Largely Avoid Gilead's Hepatitis Dive

    IBD
  53. Express Scripts Picks AbbVie HCV Drugs Over Gilead

    IBD
  54. Express Scripts Knocks Gilead's Hepatitis C Drug in Favor of ...

    GuruFocus
  55. Bank Of America Downgrades Gilead Sciences, Sees Possible Pricing ...

    Benzinga
  56. Broad Indexes Little Changed; Facebook Breaks Out

    IBD
  57. Dow Outperforms While Nasdaq Holds Small Gain; Oil Weak

    IBD
  58. Express Scripts Picks AbbVie HCV Drugs Over Gilead

    IBD
  59. Mid-Morning Market Update: Markets Open Higher; Caesars Entertainment ...

    Benzinga
  60. Stocks Struggle To Hold Gains; Alaska Air, Spirit Up

    IBD
  61. Gilead Sciences Plummets Amid AbbVie Deal With Express Scripts

    Benzinga
  62. Stock Futures Point Higher; AbbVie Surges, Gilead Dives

    IBD
  63. AbbVie's Hep C Regimen OK'd, 12-Week Cost $83,319

    IBD
  64. How Can Drugmakers Handle New Pricing Pressures?

    IBD
  65. Are These Drugstore Retailers Good Investments?

    GuruFocus
  66. AmerisourceBergen a Key Player in the Pharma Industry

    GuruFocus
  67. Weekly 52-Week Highs Highlight: ITW, ESRX, TEVA, CHD, STI

    GuruFocus
  68. 5 Stock-Moving Medtech Events This December

    IBD
  69. Top 4 Stocks In The Health Care Plans Industry With The Highest ...

    Benzinga
  70. Surprisingly, Warren Buffett Buys These 8 Dividend Stocks

    GuruFocus
  71. Warren Buffett and CIOs Buy DirecTV, Charter Communications, ...

    GuruFocus
  72. Scour Mutual Fund Special Sections For Great Ideas

    IBD
  73. Buybacks-Driven Market: Engineered Too Far?

    YCharts
  74. #PreMarket Primer: Wednesday, October 29: Fed Likely To End Bond ...

    Benzinga
  75. Express Scripts Posts EPS In-line With Estimates

    Benzinga
  76. Stocks Tack On Gains; Centene Hits New High

    IBD
  77. AmerisourceBergen's Move To Go Big Is The Right Rx

    IBD
  78. 2015 Express Scripts Medicare Prescription Drug Plans Earn CMS ...

    Benzinga
  79. These 3 Upcoming IPOs Have Strong Investor Interest

    IBD
  80. IPO Calendar: HubSpot, Dave & Buster's Among 8 IPOs

    IBD
  81. 2 Mutual Funds Holding Hospital Stocks

    Benzinga
  82. UPDATE: Goldman Sachs Downgrades Express Scripts Holding Company

    Benzinga
  83. Benzinga's Top Downgrades

    Benzinga
  84. Goldman Sachs Downgrades Express Scripts To Neutral

    Benzinga
  85. Air Methods Navigates To Grow Medical Flight Business

    IBD
  86. Buyback ETF Slow-Footed: Better Ideas Here

    YCharts
  87. Without Its Tax Dodge, What’s Walgreen Worth?

    YCharts
  88. The Stocks Already in Correction Mode

    FoxBusiness
  89. Shares Of Express Scripts Up 5% Following Q2 Earnings

    Benzinga
  90. Quarterly “Beats”: Bah, Here Are Real Growers

    YCharts
  91. #PreMarket Primer: Tuesday, July 29: Russia Accused Of Violating ...

    Benzinga
  92. Earnings Scheduled For July 29, 2014

    Benzinga
  93. Horizon Pharma Drugs Ditched By Pharmacies; Stock Falls

    IBD
  94. Is Walgreen Set For A Better 2014?

    GuruFocus
  95. Morning Market Losers

    Benzinga
  96. Benzinga's Top #PreMarket Losers

    Benzinga
  97. Benzinga Weekly Preview: FOMC In Focus, As Earnings Season Progresses

    Benzinga
  98. Dodge & Cox Second Quarter 2014 Commentary

    GuruFocus
  99. #PreMarket Primer: Friday, July 18: Tension Between Russia And ...

    Benzinga
  100. Walgreen Tax Inversion: Masking A Weak Business?

    YCharts
Trading Center